Mycobacterium ulcerans Mouse Model Refinement for Pre-Clinical Profiling of Vaccine Candidates

被引:8
|
作者
Benard, Angele [1 ,3 ]
Sala, Claudia [2 ]
Pluschke, Gerd [1 ]
机构
[1] Swiss Trop & Publ Hlth Inst, Basel, Switzerland
[2] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland
[3] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England
来源
PLOS ONE | 2016年 / 11卷 / 11期
关键词
BURULI ULCER; DIVERSITY; MICE; SUSCEPTIBILITY; MYCOLACTONE; INFECTION; EVOLUTION; ECOLOGY; LESIONS; TOXIN;
D O I
10.1371/journal.pone.0167059
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Buruli Ulcer is a neglected tropical disease leading to extensive disabilities and morbidity in West Africa. In this paper we sought to characterize various strains of Mycobacterium ulcerans (M. ulcerans) with different origins and laboratory passage records while refining a mouse model for Buruli ulcer. We described, compared and followed the kinetics of the histo-pathological outcome of infection of a collection of strains at various anatomical sites of infection in order to find a suitable model for further immunization studies. Moreover we compared the outcome of infection in C57Bl/6 and Balbc/J mice. Specifically we described thoroughly one M. ulcerans strain characterized by slow growth rate and limited tissue necrosis, which presents close ressemblance with the infection kinetics in humans. This strain caused macrophages as well as T and B cells infiltration, correlating with mycobacterial proliferation at the site of infection as well as in the draining lymph nodes, making it a suitable strain to screen vaccine candidates efficacy.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Pre-clinical safety evaluation for mRNA-vaccine development in mouse model
    Ahn, J. H.
    Kwak, J. A.
    Kim, J. I.
    You, J. R.
    Cho, E. Y.
    Kwon, E. A.
    Keum, G. C.
    Nam, J. H.
    Yun, J. W.
    Kang, B. C.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A197 - A197
  • [2] Pre-clinical evaluation of vaccine candidates for the prevention of infection by Chlamydia trachomatis
    Heinrichs, Jon
    Wooters, Melissa
    Kaufhold, Robin
    Field, Jodie
    Zhong, Guangming
    Smith, Jeffrey
    INFLAMMATION RESEARCH, 2010, 59 : S108 - S108
  • [3] Pre-Clinical Bioimaging in a Mouse Model of Rheumatoid Arthritis
    Ierna, Michelle
    Smith, Karen
    Ross, Kirsty
    Meiklejohn, Gordon
    Maffia, Pasquale
    Brewer, James M.
    McInnes, Iain B.
    Garside, Paul
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S75 - S75
  • [4] The Role of Biological Sex in Pre-Clinical (Mouse) mRNA Vaccine Studies
    Binici, Burcu
    Rattray, Zahra
    Schroeder, Avi
    Perrie, Yvonne
    VACCINES, 2024, 12 (03)
  • [5] Novel Vaccine Targeting Colonic Adenoma: a Pre-clinical Model
    Toan Pham
    Sandra Carpinteri
    Shienny Sampurno
    Lloyd Pereira
    Sara Roth
    Vignesh Narasimhan
    Phillip Darcy
    Jayesh Desai
    Alexander G. Heriot
    Robert G. Ramsay
    Journal of Gastrointestinal Surgery, 2019, 23 : 626 - 633
  • [6] Novel Vaccine Targeting Colonic Adenoma: a Pre-clinical Model
    Pham, Toan
    Carpinteri, Sandra
    Sampurno, Shienny
    Pereira, Lloyd
    Roth, Sara
    Narasimhan, Vignesh
    Darcy, Phillip
    Desai, Jayesh
    Heriot, Alexander G.
    Ramsay, Robert G.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (03) : 626 - 633
  • [7] Novel vaccine targeting colonic adenoma: A pre-clinical model
    Pham, Toan D.
    Carpinteri, Sandra
    Sampurno, Shienny
    Pereira, Lloyd
    Roth, Sara
    Narasimhan, Vignesh
    Wilson, Kasmira
    Darcy, Phillip
    Desai, Jayesh
    Heriot, Alexander G.
    Ramsay, Robert G.
    CANCER RESEARCH, 2019, 79 (13)
  • [8] Pre-clinical model of a genetically arrested experimental malaria vaccine
    Haussig, J.
    Burgold, J.
    Matuschewski, K.
    Kooij, T.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2013, 18 : 65 - 65
  • [9] Pre-clinical primate vaccine studies
    Thorstensson, R
    INTERNATIONAL SEMINAR ON NUCLEAR WAR AND PLANETARY EMERGENCIES - 30TH SESSION, 2004, : 243 - 246
  • [10] The mutant p53 mouse as a pre-clinical model
    Jackson, J. G.
    Lozano, G.
    ONCOGENE, 2013, 32 (37) : 4325 - 4330